Association of COVID-19-Associated Pulmonary Aspergillosis with Cytomegalovirus Replication: A Case–Control Study

Association of COVID-19-Associated Pulmonary Aspergillosis with Cytomegalovirus Replication: A Case–Control Study

<b>Introduction:</b> Cytomegalovirus (CMV) infection is a well-known factor associated with invasive aspergillosis in immunocompromised hosts. However, its association with COVID-19-associated pulmonary aspergillosis (CAPA) has not been described. We aimed to examine the possible link be...

Full description

Bibliographic Details
Main Authors:	Jorge Calderón-Parra, Victor Moreno-Torres, Patricia Mills-Sanchez, Sandra Tejado-Bravo, Isabel Romero-Sánchez, Bárbara Balandin-Moreno, Marina Calvo-Salvador, Francisca Portero-Azorín, Sarela García-Masedo, Elena Muñez-Rubio, Antonio Ramos-Martinez, Ana Fernández-Cruz
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Series:	Journal of Fungi
Subjects:	COVID-associated pulmonary aspergillosis CAPA prevalence risk factors cytomegalovirus infection
Online Access:	https://www.mdpi.com/2309-608X/8/2/161

Similar Items

COVID-19-Associated Pulmonary Aspergillosis in a Tertiary Hospital
by: García-Clemente Marta, et al.
Published: (2022-01-01)

Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis
by: Armani M. Hawes, et al.
Published: (2022-11-01)

COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis
by: Shiang-Fen Huang, et al.
Published: (2023-06-01)

COVID-19 Associated Pulmonary Aspergillosis (CAPA): Hospital or Home Environment as a Source of Life-Threatening <i>Aspergillus fumigatus</i> Infection?
by: Teresa Peláez-García de la Rasilla, et al.
Published: (2022-03-01)

Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis
by: H. Carlo Maurer, et al.
Published: (2022-11-01)

Long-Term Follow-Up of Patients Diagnosed with COVID-19-Associated Pulmonary Aspergillosis (CAPA)
by: María Ruiz-Ruigómez, et al.
Published: (2022-08-01)

COVID-19 Associated Pulmonary Aspergillosis: A Case Series
by: Mira Yulianti, et al.
Published: (2022-04-01)

An unusual case of early cytomegalovirus retinitis with UTI, invasive pulmonary aspergillosis, Klebsiella Pneumonia in a renal allograft recipient
by: Preeti Chaudhary, et al.
Published: (2023-01-01)

Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave
by: Robbert G. Bentvelsen, et al.
Published: (2022-01-01)

Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients
by: Rasmus Leistner, et al.
Published: (2022-01-01)

COVID-19-Associated Pulmonary Aspergillosis: A Single-Center Experience in Central Valley, California, January 2020–March 2021
by: Geetha Sivasubramanian, et al.
Published: (2021-11-01)

Influenza- and COVID-19-Associated Pulmonary Aspergillosis: Are the Pictures Different?
by: Florian Reizine, et al.
Published: (2021-05-01)

COVID-19-Associated Pulmonary Aspergillosis in Russia
by: Olga Shadrivova, et al.
Published: (2021-12-01)

A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
by: Simon Feys, et al.
Published: (2021-12-01)

Invasive Pulmonary Aspergillosis in Patients with and without SARS-CoV-2 Infection
by: Jesús Fortún, et al.
Published: (2023-01-01)

Does Post-Transplant Cytomegalovirus Increase the Risk of Invasive Aspergillosis in Solid Organ Transplant Recipients? A Systematic Review and Meta-Analysis
by: Nipat Chuleerarux, et al.
Published: (2021-04-01)

COVID-19 associated pulmonary aspergillosis (CAPA): An Australian case report
by: Avinash Sharma, et al.
Published: (2021-03-01)

COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit Patients from Poland
by: Magdalena Skóra, et al.
Published: (2023-06-01)

Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study
by: Stefan Hatzl, et al.
Published: (2021-09-01)

Mortality in ICU Patients with COVID-19-Associated Pulmonary Aspergillosis
by: Anna Beltrame, et al.
Published: (2023-06-01)

Novel Clinical and Laboratorial Challenges in Aspergillosis
by: Raquel Sabino, et al.
Published: (2022-01-01)

Challenges in Diagnosing COVID-19-Associated Pulmonary Aspergillosis in Critically Ill Patients: The Relationship between Case Definitions and Autoptic Data
by: Giacomo Casalini, et al.
Published: (2022-08-01)

COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility
by: Nina Lackner, et al.
Published: (2022-01-01)

The Prognostic Role of Diagnostic Criteria for COVID-19-Associated Pulmonary Aspergillosis: A Cross-Sectional Retrospective Study
by: Erika Asperges, et al.
Published: (2024-02-01)

Population Pharmacokinetics of Isavuconazole in Critical Care Patients with COVID-19-Associated Pulmonary Aspergillosis and Monte Carlo Simulations of High Off-Label Doses
by: Lucas Perez, et al.
Published: (2023-02-01)

Association between Pulmonary Aspergillosis and <i>Cytomegalovirus</i> Reactivation in Critically Ill COVID-19 Patients: A Prospective Observational Cohort Study
by: Valeria Caciagli, et al.
Published: (2023-11-01)

Invasive Pulmonary Aspergillosis in Patients with SARS-CoV-2 Infection: A Systematic Review of the Literature
by: Anna Apostolopoulou, et al.
Published: (2020-10-01)

Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant
by: Yixuan Wang, et al.
Published: (2024-01-01)

Seroprevalence of Galactomannan Aspergillus in COVID-19 patients in Jakarta: A challenge in the pandemic commotion
by: Anna Rozaliyani
Published: (2023-07-01)

Invasive pulmonary aspergillosis in COVID-19 patients
by: V. G. Gusarov, et al.
Published: (2021-03-01)

"Aspergillosis following Cytomegalovirus disease in a kidney transplant patient "
by: "Ameri Sh, et al.
Published: (2003-06-01)

SARS-CoV-2 Associated Immune Dysregulation and COVID-Associated Pulmonary Aspergilliosis (CAPA): A Cautionary Tale
by: Dominic Adam Worku
Published: (2022-03-01)

Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience
by: Istemi Serin, et al.
Published: (2022-11-01)

COVID-19-Associated Pulmonary Aspergillosis (CAPA) in Northern Greece during 2020–2022: A Comparative Study According to the Main Consensus Criteria and Definitions
by: Panagiotis Siasios, et al.
Published: (2023-01-01)

Invasive aspergillosis a complication severe respiratory viral infections (influenza and COVID-19)
by: N. N. Klimko, et al.
Published: (2021-12-01)

Significance of Aspergillus spp. isolation in defining cases of COVID-19 Associated Pulmonary Aspergillosis – CAPA
by: Tiago Alexandre Cocio, et al.
Published: (2023-07-01)

A Laboratory-Based Study on Multiple Biomarker Testing in the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): Real-Life Data
by: Cornelia Lass-Flörl, et al.
Published: (2022-12-01)

Isavuconazole for COVID-19-Associated Invasive Mold Infections
by: Nadir Ullah, et al.
Published: (2022-06-01)

Unusual manifestation of COVID‐19‐associated pulmonary aspergillosis: A case report
by: Maryam Albaji, et al.
Published: (2022-08-01)

Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements
by: G. Montrucchio, et al.
Published: (2021-09-01)